Home » Stocks » CEMI

Chembio Diagnostics, Inc. (CEMI)

Stock Price: $6.31 USD 0.11 (1.77%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $6.40 +0.09 (1.43%) Jan 22, 7:53 PM
Market Cap 127.31M
Revenue (ttm) 29.09M
Net Income (ttm) -22.27M
Shares Out 20.10M
EPS (ttm) -1.22
PE Ratio n/a
Forward PE 6.72
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $6.31
Previous Close $6.20
Change ($) 0.11
Change (%) 1.77%
Day's Open 6.18
Day's Range 6.12 - 6.32
Day's Volume 679,420
52-Week Range 2.36 - 15.54

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 month ago

HAUPPAUGE, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appo...

Zacks Investment Research - 1 month ago

Investors need to pay close attention to Chembio Diagnostics (CEMI) stock based on the movements in the options market lately.

Zacks Investment Research - 1 month ago

Chembio Diagnostics (CEMI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

GlobeNewsWire - 1 month ago

HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious diseases, today announced it has be...

Insider Monkey - 1 month ago

In this article we will take a look at whether hedge funds think Chembio Diagnostics Inc (NASDAQ:CEMI) is a good investment right now. We check hedge fund and billionaire investor sentiment be...

GlobeNewsWire - 2 months ago

HAUPPAUGE, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that its...

Seeking Alpha - 2 months ago

Chembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

HAUPPAUGE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financia...

GlobeNewsWire - 3 months ago

HAUPPAUGE, N.Y., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it...

GlobeNewsWire - 3 months ago

Rapid Test Provides Results in Only 20 Minutes Rapid Test Provides Results in Only 20 Minutes

GlobeNewsWire - 3 months ago

First Rapid Test Approved in U.S. to Aid in Diagnosis of Both HIV and Syphilis from Single Patient Sample First Rapid Test Approved in U.S. to Aid in Diagnosis of Both HIV and Syphilis from Si...

Zacks Investment Research - 3 months ago

Investors need to pay close attention to Chembio (CEMI) stock based on the movements in the options market lately.

GlobeNewsWire - 4 months ago

New Antibody Test System Provides Results in 15 Minutes from Finger Stick, Venous Whole Blood, Plasma, or Serum Samples New Antibody Test System Provides Results in 15 Minutes from Finger Stic...

Zacks Investment Research - 4 months ago

Investors need to pay close attention to Chembio Diagnostics (CEMI) stock based on the movements in the options market lately.

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 17, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Chembio...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 17, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securi...

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 16, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Chembio...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 14, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Chembio Diagnostics, Inc.

Business Wire - 5 months ago

LOS ANGELES--(BUSINESS WIRE)---- $CEMI #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming August 17, 2020 deadline to file a lead plaintiff motion in the class ac...

PRNewsWire - 5 months ago

PHILADELPHIA, Aug. 14, 2020 /PRNewswire/ -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Chembio Diagnostics, Inc.

Business Wire - 5 months ago

RADNOR, Pa.--(BUSINESS WIRE)---- $CEMI #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP reminds Chembio Diagnostics, Inc.

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 13, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Chembi...

Business Wire - 5 months ago

NEW YORK--(BUSINESS WIRE)-- #CEMI--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United ...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 12, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Chembio Diagnostics, Inc.

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 12, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Chembi...

Business Wire - 5 months ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Chembio Diagnostics, Inc. ("Chembio" or "the Company") (NASDA...

Seeking Alpha - 5 months ago

Chembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

RADNOR, Pa., Aug. 7, 2020 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Chembio Diagno...

PRNewsWire - 5 months ago

NEW YORK, July 28, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 20...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - July 27, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Chembio Diagnostics, Inc.

PRNewsWire - 5 months ago

RADNOR, Pa., July 24, 2020 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Chembio Diagn...

GlobeNewsWire - 6 months ago

HAUPPAUGE, N.Y., July 23, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that ...

Zacks Investment Research - 6 months ago

Investors need to pay close attention to Chembio Diagnostics (CEMI) stock based on the movements in the options market lately.

Business Wire - 6 months ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 1...

Business Wire - 6 months ago

SAN DIEGO & SALT LAKE CITY--(BUSINESS WIRE)---- $CEMI #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Chembio Diagnostics, Inc. (NASDAQ: CEMI) filed...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - July 15, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Chembio Diagnostics, Inc. ("Chem...

Zacks Investment Research - 6 months ago

Chembio Diagnostics (CEMI) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.

PRNewsWire - 6 months ago

NEW YORK, July 6, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Chembio Diagnostics, Inc. ("Chembio" or the "Company") (NASDAQ: CEMI) and cert...

GlobeNewsWire - 6 months ago

Company to Host Conference Call Tuesday, July 7 Company to Host Conference Call Tuesday, July 7

GlobeNewsWire - 6 months ago

HAUPPAUGE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading global point-of-care diagnostic company focused on infectious diseases, today announced...

GlobeNewsWire - 6 months ago

HAUPPAUGE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has...

Business Wire - 6 months ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ: CEMI) between March 12, 2020 and June 1...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - July 1, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securitie...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - June 29, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Chembio Diagnostics, Inc. (NASDAQ:...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - June 29, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securit...

Business Wire - 6 months ago

RADNOR, Pa.--(BUSINESS WIRE)---- $CEMI #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against Ch...

Business Wire - 6 months ago

SAN DIEGO & SALT LAKE CITY--(BUSINESS WIRE)---- $CEMI #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Chembio Diagnostics, Inc. (NASDAQ: CEMI) filed a class...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - June 26, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Chembio Diagnostics, Inc. (NASDAQ:...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - June 25, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI) ("Chembio" o...

PRNewsWire - 6 months ago

RADNOR, Pa., June 25, 2020 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Chembio Diagn...

About CEMI

Chembio Diagnostics, together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for HIV and Syphilis, and Zika virus. It also develops tests for malaria, Dengue virus, chikungunya virus, ebola, lassa, marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi. In addition, the company develops tests for a specific form of cancer, concussion, and bovine tuberculosis; and handheld optical... [Read more...]

Industry
Diagnostics & Research
IPO Date
Oct 18, 2000
Stock Exchange
NASDAQ
Ticker Symbol
CEMI
Full Company Profile

Financial Performance

In 2019, CEMI's revenue was $34.46 million, a decrease of -0.34% compared to the previous year's $34.58 million. Losses were -$13.68 million, 73.9% more than in 2018.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for CEMI stock is "Buy." The 12-month stock price forecast is 9.00, which is an increase of 42.63% from the latest price.

Price Target
$9.00
(42.63% upside)
Analyst Consensus: Buy